Study to Predict Lanreotide-induced Disease Activity Normalization in Acromegaly
NCT04003519
·
clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Study timeline delay, low site feasibility and delay concerns due to COVID-19.
Conditions
Acromegaly
Sponsor
Ipsen